RiVive (naloxone HCl nasal spray 3 mg) is available for 501(c)(3), 501(c)(4), 501(a) organizations to purchase to help save lives that would have otherwise been lost due to opioid overdose.
Organizations are subject to approval by Harm Reduction Therapeutics and include, but are not limited to, Community Treatment Centers, EMS, Fire Departments, Public Safety Departments, Federal and State Government Agencies and other harm reduction organizations.
(* denotes mandatory field)